Home · Peptides · Dihexa
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Dihexa

THE MEMORY AMPLIFIER

DiHexa; PNB-0408; N-hexanoic-Tyr-Ile-(6)-amino-hexanoic amide

Dihexa is a synthetic peptide derived from angiotensin IV that's shown unusually strong synapse-forming activity in preclinical studies. It activates the HGF/c-Met pathway, the same system that helps your brain repair itself, and does so millions of times more potently than BDNF. It promotes new synapse formation and may help with Alzheimer's and Parkinson's.

Dihexa
Dihexa
Dihexa

Dihexa Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Dihexa

◆

Is Dihexa FDA approved?

No. This profile records Dihexa as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Dihexa?

Dose: 10-20 mg daily (oral or transdermal).

MORE CONTEXT ›

Schedule: daily. Cycle: 6 weeks on, 6 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Dihexa guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

HGF/c-Met Activation

Powerfully activates brain growth and repair pathways

Synaptogenesis

Promotes formation of new brain connections

Anti-Inflammatory

Reduces neuroinflammation and microglial overactivation

People with cognitive decline
Those seeking powerful nootropic effects
Alzheimer's or Parkinson's patients (research)
Researchers studying neuroregeneration

Dihexa Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.